04/02/2024 3:21 PM | BioCryst Pharmaceuticals (Issuer) Thackray Helen M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:32 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:02 AM | Avoro Capital Advisors LLC (Filed by) BioCryst Pharmaceuticals (Subject)
| Form SC 13G | |
01/24/2024 4:23 PM | BioCryst Pharmaceuticals (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024 12:06 PM | BioCryst Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 4:21 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
01/08/2024 6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) Stonehouse Jon P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:42 PM | BioCryst Pharmaceuticals (Issuer) Thackray Helen M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:33 PM | Barnes Alane P (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:35 PM | BioCryst Pharmaceuticals (Issuer) Doyle Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:38 PM | BioCryst Pharmaceuticals (Issuer) Gayer Charles K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) Gayer Charles K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:43 PM | BioCryst Pharmaceuticals (Issuer) Stonehouse Jon P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:47 PM | BioCryst Pharmaceuticals (Issuer) Thackray Helen M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:34 PM | Barnes Alane P (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:37 PM | BioCryst Pharmaceuticals (Issuer) Doyle Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:42 PM | BioCryst Pharmaceuticals (Issuer) MILANO VINCENT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 8:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 3:29 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/03/2023 11:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 11:16 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/26/2023 8:36 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:41 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:43 PM | BioCryst Pharmaceuticals (Issuer) MILANO VINCENT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 6:04 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 6:00 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 6:33 AM | BioCryst Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023 3:40 PM | BioCryst Pharmaceuticals (Issuer) Galson Steven K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:42 PM | BioCryst Pharmaceuticals (Issuer) LEE KENNETH B JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:43 PM | BioCryst Pharmaceuticals (Issuer) LEVIN ALAN G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:50 PM | BioCryst Pharmaceuticals (Issuer) Stonehouse Jon P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:31 PM | BioCryst Pharmaceuticals (Issuer) McKee Amy E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:33 PM | BioCryst Pharmaceuticals (Issuer) Hutson Nancy J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:35 PM | BioCryst Pharmaceuticals (Issuer) MILANO VINCENT (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:37 PM | BioCryst Pharmaceuticals (Issuer) SANDERS MACHELLE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:39 PM | ASELAGE STEVE (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad) Don't Buy Bullion or Mining Stocks. Do THIS Instead
As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. |
06/15/2023 3:28 PM | ABERCROMBIE GEORGE B (Reporting) BioCryst Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:29 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 9:19 AM | BioCryst Pharmaceuticals (Subject) SANDERS MACHELLE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023 10:32 AM | BioCryst Pharmaceuticals (Subject) Hutson Nancy J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023 6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 3:32 PM | BioCryst Pharmaceuticals (Issuer) HEGGIE THERESA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:08 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |